Farther Finance Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.4K Buy
430
+367
+583% +$13.2K ﹤0.01% 4197
2026
Q1
$2.24K Sell
63
-132
-68% -$5.37K ﹤0.01% 4864
2025
Q4
$7.92K Buy
195
+180
+1,200% +$7.83K ﹤0.01% 4063
2025
Q3
$705 Buy
15
+8
+114% +$415 ﹤0.01% 4454
2025
Q2
$365 Sell
7
-1
-13% -$55 ﹤0.01% 4105
2025
Q1
$475 Sell
8
-4
-33% -$258 ﹤0.01% 3785
2024
Q4
$821 Sell
12
-15
-56% -$1.04K ﹤0.01% 3309
2024
Q3
$1.94K Sell
27
-8
-23% -$564 ﹤0.01% 3003
2024
Q2
$2.35K Sell
35
-44
-56% -$3.21K ﹤0.01% 2728
2024
Q1
$6.24K Buy
79
+32
+68% +$2.85K ﹤0.01% 1964
2023
Q4
$5.15K Buy
+47
New +$4.86K ﹤0.01% 1954
2023
Q3
Sell
-55
Closed -$7.47K 2631
2023
Q2
$7.47K Hold
55
﹤0.01% 1291
2023
Q1
$5.71K Buy
+55
New +$5.32K ﹤0.01% 1297

Other funds holding CNMD

Farther Finance Advisors's CNMD Position: Q2 2026 in Review

Farther Finance Advisors increased its CONMED (CNMD) stake by 583% in Q2 2026, buying an estimated $13.2K and bringing the position to 430 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4197.

Farther Finance Advisors first reported a position in CNMD in Q1 2023 and has held it in 13 quarters since. 42 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Farther Finance Advisors held 430 shares of CONMED worth $14.4K as of Q2 2026.
  • Farther Finance Advisors bought 367 CONMED shares in Q2 2026, an estimated $13.2K.
  • CONMED made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4197 holding.
  • Farther Finance Advisors first reported a position in CONMED in Q1 2023 and has held it in 13 quarters since.
  • 42 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.